Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Applied DNA Sciences Inc
APDN
Healthcare
Medical Instruments & Supplies
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services...
segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:APDN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
Next
(7)
•••
turner20001
X
Post by
turner20001
on Nov 06, 2023 2:53pm
Why hasn't APDN ever been profitable for over 20 years?
Why hasn't applied DNA Sciences ever been profitable for over 20 years? Applied DNA Sciences has faced several challenges that have contributed to its lack of profitability over
...more
(7)
•••
turner20001
X
Post by
turner20001
on Nov 06, 2023 2:46pm
APDN's Competitors
Applied DNA Sciences (APDN) operates in the biotechnology industry, specifically in the area of DNA-based anti-counterfeiting and authentication solutions. The company's main competitors
...more
(7)
•••
turner20001
X
Post by
turner20001
on Nov 03, 2023 4:21pm
Pfizer gets access to Touchlight's 'doggybone DNA'
Pfizer has turned itself into a household name amid the pandemic, but it's routinely looking at ways to improve on its operations. In one approach, the company is exploring next-gen "
...more
(7)
•••
turner20001
X
Post by
turner20001
on Oct 18, 2023 4:49pm
Applied DNA stock downgraded to Strong Sell Candidate
Applied DNA stock downgraded to Strong Sell Candidate (Updated on Oct 17, 2023) Sell candidate since Oct 02, 2023 Loss -11.40% PDF The Applied DNA stock
...more
(7)
•••
turner20001
X
Post by
turner20001
on Oct 18, 2023 4:46pm
Did You Manage To Avoid Applied DNA Sciences's (NASDAQ:APDN)
Did You Manage To Avoid Applied DNA Sciences's (NASDAQ:APDN) 96% Share Price Wipe Out? Simply Wall St Mon, Dec 2, 2019 Long term investing is the way to
...more
(7)
•••
turner20001
X
Post by
turner20001
on Oct 06, 2023 5:09pm
CEO Hayward's partner Sidney Braginsky
Unfortunately this doesn't conclude the Braginsky saga, as from 1994 to 2000 he served as the President of Olympus America Inc. Olympus lawsuit (Case No. 11-cv-7103) alleged "financial fraud
...more
(7)
•••
turner20001
X
Post by
turner20001
on Oct 06, 2023 5:06pm
The Braginsky Affair
Hayward's longtime business buddy, Sidney Braginsky was also on the Board of Q-RNA and serves as the managing director of the Double D Venture Funds LLC. Braginsky's
...more
(7)
•••
turner20001
X
Post by
turner20001
on Oct 05, 2023 1:33pm
A Big Bill but Little Payoff for CUNY’s COVID Testing System
A Big Bill but Little Payoff for CUNY’s COVID Testing System. The program began in the summer of 2021 when the city’s sprawling university system, with 25 campuses and nearly a quarter-million
...more
(7)
•••
turner20001
X
Post by
turner20001
on Oct 02, 2023 3:49pm
SHOCKING AI REVELATIONS!
Here are some specific examples of the false and misleading statements that APDN has been accused of making: APDN has claimed that its DNA-based anti-counterfeiting technology is "uncopyable
...more
(7)
•••
turner20001
X
Post by
turner20001
on Sep 26, 2023 3:34pm
Khang & Khang LLP Announces an Investigation of APDN
INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Claims Against Applied DNA Sciences Inc. and Advises Investors to Contact the Firm.
(7)
•••
turner20001
X
Post by
turner20001
on Sep 26, 2023 1:44pm
Applied DNA Sciences, Inc. Loses Appeals on Former Employees
The California Unemployment Appeals Board has ruled against Applied DNA Sciences, Inc. (OTCBB:APDN) in its effort to disqualify three former employees from receiving unemployment insurance benefits
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 14, 2023 9:02am
New Press Release - Applied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals
Agreement Focuses on the Accelerated Development of LNP-encapsulated LineaDNA™ Vaccines to Eliminate the Use of Plasmid DNA and Reduce the Dependence on Extreme Cold Chains of Today's mRNA VaccinesSTONY BROOK, NY and ITHACA, NY / ACCESSWIRE / September 14, 2023 / Applied DNA Sciences, Inc...
read article.
(7)
•••
turner20001
X
Post by
turner20001
on Sep 07, 2023 4:34pm
Sorry Hayward, you're technology is way behind
Sorry Hayward, you're technology is way behind the competition and you need to stop fooling the investors of this company. Let's show the audience the evidence (that's right little Nina
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 06, 2023 9:01am
New Press Release - Applied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
Experienced Biopharma/Pharmaceutical Executive to Lead Implementation of cGMP-quality LineaDNA™ Capability for IVT mRNA ProductionPreviously Led Manufacturing Operations Scale-up for the BioNTech/Pfizer mRNA COVID-19 Vaccine at CDMO Division of Maravai LifeSciencesSTONY BROOK, NY / ACCESSWIRE...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 29, 2023 9:02am
New Press Release - Applied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit
STONY BROOK, NY / ACCESSWIRE / August 29, 2023 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the general availability of Linea™ IVT platform evaluation kits (the "Kit") and the first shipment of a Kit to an...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >